CENTESSA PHARMACEUTICALS PLC - AMERICAN DEPOSITARY

Centessa Pharmaceuticals Announces Addition to NASDAQ Biotechnology Index

13 Dec 2021 15:15:00 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

15 Nov 2021 06:00:03 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021

10 Nov 2021 15:45:00 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Demonstrates Proof-of-Mechanism from First Three PiMZ Subjects Dosed in Part B of Phase 1 Study Evaluating ZF874

01 Nov 2021 06:30:00 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists

18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

05 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital

04 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis

09 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

01 Sep 2021 15:15:00 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Updates

16 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

07 Jun 2021 15:15:00 By Nasdaq GlobeNewswire